Topics

No keywords indexed for this article. Browse by subject →

References
46
[1]
Alassane-Kpembi "New insights into mycotoxin mixtures: the toxicity of low doses of Type B trichothecenes on intestinal epithelial cells is synergistic" Toxicol. Appl. Pharmacol. (2013) 10.1016/j.taap.2013.05.023
[2]
Bensassi "In vitro investigation of toxicological interactions between the fusariotoxins deoxynivalenol and zearalenone" Toxicon (2014) 10.1016/j.toxicon.2014.03.005
[3]
Bravin "In vitro cytochrome p450 formation of a mono-hydroxylated metabolite of zearalenone exhibiting estrogenic activities: possible occurrence of this metabolite in vivo" Int. J. Mol. Sci. (2009) 10.3390/ijms10041824
[4]
Cortinovis "Fusarium mycotoxins: effects on reproductive function in domestic animals–a review" Theriogenology (2013) 10.1016/j.theriogenology.2013.06.018
[5]
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement

Evanthia Diamanti-Kandarakis, Jean-Pierre Bourguignon, Linda C. Giudice et al.

Endocrine Reviews 2009 10.1210/er.2009-0002
[6]
Eriksen "Absorption, metabolism and excretion of 3-acetyl DON in pigs" Arch. Tierernahr (2003)
[7]
Ermler "The suitability of concentration addition for predicting the effects of multi-component mixtures of up to 17 anti-androgens with varied structural features in an in vitro AR antagonist assay" Toxicol. Appl. Pharmacol. (2011) 10.1016/j.taap.2011.09.005
[8]
Evans "Additive mixture effects of estrogenic chemicals in human cell-based assays can be influenced by inclusion of chemicals with differing effect profiles" PLoS One (2012) 10.1371/journal.pone.0043606
[9]
FAO/WHO (2011)
[10]
Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis

C. Frizzell, D. Ndossi, S. Verhaegen et al.

Toxicology Letters 2011 10.1016/j.toxlet.2011.07.015
[11]
Frizzell "An in vitro investigation of endocrine disrupting effects of the mycotoxin alternariol" Toxicol. Appl. Pharmacol. (2013) 10.1016/j.taap.2013.05.002
[12]
Frizzell "Endocrine disrupting effects of ochratoxin A at the level of nuclear receptor activation and steroidogenesis" Toxicol. Lett. (2013) 10.1016/j.toxlet.2012.12.018
[13]
Fung "Health effects of mycotoxins: a toxicological overview" J. Toxicol. Clin. Toxicol. (2004) 10.1081/clt-120030947
[14]
Gijsbers "Stable reporter cell lines for peroxisome proliferator-activated receptor gamma (PPARgamma)-mediated modulation of gene expression" Anal. Biochem. (2011) 10.1016/j.ab.2011.02.032
[15]
Grenier "Mycotoxin co-contamination of food and feed: meta-analysis of publications describing toxicological interactions" World Mycotoxin J. (2011) 10.3920/wmj2011.1281
[16]
Houtman "Biological validation of a sample preparation method for ER-CALUX bioanalysis of estrogenic activity in sediment using mixtures of xeno-estrogens" Environ. Sci. Technol. (2006) 10.1021/es051698p
[17]
Huybrechts "Fast and sensitive LC-MS/MS method measuring human mycotoxin exposure using biomarkers in urine" Arch. Toxicol. (2014) 10.1007/s00204-014-1358-8
[18]
Kjaerstad "Mixture effects of endocrine disrupting compounds in vitro" Int. J. Androl. (2010) 10.1111/j.1365-2605.2009.01034.x
[19]
Kuiper-Goodman "Risk assessment of the mycotoxin zearalenone" Regul. Toxicol. Pharmacol. (1987) 10.1016/0273-2300(87)90037-7
[20]
Leesnitzer "Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662" Biochemistry (2002) 10.1021/bi0159581
[21]
Lehmann "Estrogenic and clastogenic potential of the mycotoxin alternariol in cultured mammalian cells" Food Chem. Toxicol. (2006) 10.1016/j.fct.2005.08.013
[22]
Über Kombinationswirkungen

S. Loewe, H. Muischnek

Archiv für Experimentelle Pathologie und Pharmakol... 1926 10.1007/bf01952257
[23]
Marin "Mycotoxins: occurrence, toxicology, and exposure assessment" Food Chem. Toxicol. (2013) 10.1016/j.fct.2013.07.047
[24]
Massart "Oestrogenic mycotoxin exposures and precocious pubertal development" Int. J. Androl. (2010) 10.1111/j.1365-2605.2009.01009.x
[25]
Milicevic "Real and perceived risks for mycotoxin contamination in foods and feeds: challenges for food safety control" Toxins (Basel) (2010) 10.3390/toxins2040572
[26]
In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors

José-Manuel Molina-Molina, Esperanza Amaya, Marina Grimaldi et al.

Toxicology and Applied Pharmacology 2013 10.1016/j.taap.2013.05.015
[27]
Molina-Molina "Assessment of estrogenic and anti-androgenic activities of the mycotoxin zearalenone and its metabolites using in vitro receptor-specific bioassays" Food Chem. Toxicol. (2014) 10.1016/j.fct.2014.10.008
[28]
Ndossi "An in vitro investigation of endocrine disrupting effects of trichothecenes deoxynivalenol (DON), T-2 and HT-2 toxins" Toxicol. Lett. (2012) 10.1016/j.toxlet.2012.09.005
[29]
O'Brien "Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity" Eur. J. Biochem. (2000) 10.1046/j.1432-1327.2000.01606.x
[30]
Payne "Prediction and assessment of the effects of mixtures of four xenoestrogens" Environ. Health Perspect. (2000) 10.1289/ehp.00108983
[31]
Richter "In vivo effects of bisphenol A in laboratory rodent studies" Reprod. Toxicol. (2007) 10.1016/j.reprotox.2007.06.004
[32]
Safe "Problems for risk assessment of endocrine-active estrogenic compounds" Environ. Health Perspect. (2002) 10.1289/ehp.02110s6925
[33]
Scippo "Receptor-based screening assays: new perspectives in anti-doping control" Chromatographia (2004) 10.1365/s10337-004-0235-7
[34]
Shi "Thyroid hormone disrupting activities associated with phthalate esters in water sources from Yangtze River Delta" Environ. Int. (2012) 10.1016/j.envint.2011.05.013
[35]
Sonneveld "Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays" Toxicol. Sci. (2005) 10.1093/toxsci/kfi005
[36]
Streit "Current situation of mycotoxin contamination and co-occurrence in animal feed–focus on Europe" Toxins (Basel) (2012) 10.3390/toxins4100788
[37]
Streit "Mycotoxin occurrence in feed and feed raw materials worldwide: long-term analysis with special focus on Europe and Asia" J. Sci. Food Agric. (2013) 10.1002/jsfa.6225
[38]
Tammer "Combined effects of mycotoxin mixtures on human T cell function" Toxicol. Lett. (2007) 10.1016/j.toxlet.2007.02.012
[39]
Tatay "Interactive effects of zearalenone and its metabolites on cytotoxicity and metabolization in ovarian CHO-K1 cells" Toxicol InVitro (2014) 10.1016/j.tiv.2013.06.025
[40]
Tiemann "In vivo and in vitro effects of the mycotoxins zearalenone and deoxynivalenol on different non-reproductive and reproductive organs in female pigs: a review" Food Addit. Contam. (2007) 10.1080/02652030601053626
[41]
Tomaszewski "Tissue zearalenone concentration in normal, hyperplastic and neoplastic human endometrium" Ginekol. Pol. (1998)
[42]
Van Veldhoven "Do sphingoid bases interact with the peroxisome proliferator activated receptor alpha (PPAR-alpha)?" Cell Signal (2000) 10.1016/s0898-6568(00)00092-9
[43]
Versilovskis "Simultaneous determination of masked forms of deoxynivalenol and zearalenone after oral dosing in rats by LC-MS/MS" World Mycotoxin J. (2012) 10.3920/wmj2012.1411
[44]
Willemsen "Use of reporter cell lines for detection of endocrine-disrupter activity" Anal. Bioanal. Chem. (2004) 10.1007/s00216-003-2217-2
[45]
Wuttke "Definition, classification and mechanism of action of endocrine disrupting chemicals" Hormones (Athens) (2010) 10.1007/bf03401276
[46]
Zinedine "Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin" Food Chem. Toxicol. (2007) 10.1016/j.fct.2006.07.030
Metrics
49
Citations
46
References
Details
Published
Oct 01, 2016
Vol/Issue
96
Pages
107-116
License
View
Funding
CODA-CERVA: RP ENDOMYCO
Cite This Article
Heidi Demaegdt, Britt Daminet, Annick Evrard, et al. (2016). Endocrine activity of mycotoxins and mycotoxin mixtures. Food and Chemical Toxicology, 96, 107-116. https://doi.org/10.1016/j.fct.2016.07.033